0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Gut & Microbiome Human Health Effects Sign in to save

Rapid Quantitative PCR Assay for the Detection of the Three Vaginal Pathogens <i>Candida</i>, <i>Gardnerella</i> and <i>Atopobium</i> as well as the Commensal <i>Lactobacillus</i> Genera

International Journal of Microbiology and Biotechnology 2021 3 citations ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 35 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Stéphanie Bornes, Olivier Camarès, Olivier Camarès, Marylise Paquet-Gachinat, Marylise Paquet-Gachinat, Philippe Veisseire, Philippe Veisseire, Jacques Ravel, Caroline Dausset, Adrien Nivoliez

Summary

Researchers developed a rapid PCR test to detect and quantify harmful vaginal bacteria in women's microbiome samples. This clinical microbiology study is unrelated to microplastic environmental research.

Models
Study Type In vitro

The vaginal microbiota balance is quite fragile and susceptible to the development of vaginosis and candidiasis. The current diagnostic method for bacterial vaginosis relies on the evaluation of different bacterial morphotypes using the Nugent score. This method is only partially in correlation with a DNA sequencing-based diagnostic or Amsel criteria used by clinicians, suggesting the need for new molecular approaches dedicated to the diagnosis of BV. The objective of this study was to develop and validate a quantitative polymerase chain reaction (qPCR) assay for the specific and rapid detection of three vaginal pathogens, <i>i.e</i>. <i>Candida, Gardnerella</i> and <i>Atopobium</i> and the commensal Lactobacillus genera. For this purpose, four oligonucleotide primer pairs were designed and tested to obtain optimal amplification of the four target genera. The qPCR assay was also tested on the non-target genera and on human DNA. The designed primers allowed specific amplification of the target organisms <i>in vitro</i> and in clinical vaginal samples. The qPCR assay designed in this study is effective to specifically detect these genera in clinical samples as a molecular technique complementary to the Nugent score. It can be used in epidemiological studies for understanding the role of these pathogens and to follow their abundance in the microbiota in disease processes such as the development of vulvovaginal candidiasis and bacterial vaginosis.

Sign in to start a discussion.

Share this paper